skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: EBSCOhost Academic Search Premier remover BACON - Mir@bel - GLOBAL_LIBRESACCES remover Base de dados/Biblioteca: ScienceDirect remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
PRM57 - ASSESSMENTS OF ECONOMIC VALUE USING FIVE DIFFERENT ONCOLOGY VALUE FRAMEWORKS (ASCO, ESMO, NCCN, MSKCC, ICER)
PRM57 - ASSESSMENTS OF ECONOMIC VALUE USING FIVE DIFFERENT ONCOLOGY VALUE FRAMEWORKS (ASCO, ESMO, NCCN, MSKCC, ICER)
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRM57 - ASSESSMENTS OF ECONOMIC VALUE USING FIVE DIFFERENT ONCOLOGY VALUE FRAMEWORKS (ASCO, ESMO, NCCN, MSKCC, ICER)

Ambavane, A ; Meier, G ; Rivolo, S ; Gani, R

Value in health, 2018-10, Vol.21, p.S364-S365 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
HTA85 Possible Impact of Orphan Threshold Reduction to 20 Million Euro in the Framework of Early Benefit Assessment and Reimbursement Price in Germany
HTA85 Possible Impact of Orphan Threshold Reduction to 20 Million Euro in the Framework of Early Benefit Assessment and Reimbursement Price in Germany
Material Type:
Artigo 		Adicionar ao Meu Espaço

HTA85 Possible Impact of Orphan Threshold Reduction to 20 Million Euro in the Framework of Early Benefit Assessment and Reimbursement Price in Germany

Batscheider, A ; Shlaen, E ; Rich, A ; Meier, C ; Weiß, K ; Kovacevic, S ; Greiner, RA

Value in health, 2022-12, Vol.25 (12), p.S312-S313 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany
POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany
Material Type:
Artigo 		Adicionar ao Meu Espaço

POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany

Gossmann, JA ; Meier, C ; Greiner, RA ; Otto, J ; Shlaen, E ; Batscheider, A

Value in health, 2022-01, Vol.25 (1), p.S124-S124 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
PMD71 - PROCESS ANALYSIS AND SIMULATION MODELING OF A COMPUTED TOMOGRAPHY (CT) OF THE BRAIN FOCUSING ON THE EXPLORATION AND ASSESSMENT OF OPERATIONAL TIME AND COST SAVINGS
PMD71 - PROCESS ANALYSIS AND SIMULATION MODELING OF A COMPUTED TOMOGRAPHY (CT) OF THE BRAIN FOCUSING ON THE EXPLORATION AND ASSESSMENT OF OPERATIONAL TIME AND COST SAVINGS
Material Type:
Artigo 		Adicionar ao Meu Espaço

PMD71 - PROCESS ANALYSIS AND SIMULATION MODELING OF A COMPUTED TOMOGRAPHY (CT) OF THE BRAIN FOCUSING ON THE EXPLORATION AND ASSESSMENT OF OPERATIONAL TIME AND COST SAVINGS

Gossmann, N. ; Reickersdorfer, R. ; Dubowicz, A. ; Meier, F. ; Schoeffski, O. ; Eichhorst, S.

Value in health, 2018-10, Vol.21, p.S255-S255 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib
Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib

Hudgens, S ; Copher, R ; Meier, G

Value in health, 2018-05, Vol.21, p.S35 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib
Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib

Hudgens, S ; Copher, R ; Meier, G

Value in health, 2018-05, Vol.21, p.S37 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
PCN151 - Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib
PCN151 - Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib
Material Type:
Artigo 		Adicionar ao Meu Espaço

PCN151 - Longitudinal Analysis Of Adjusted EQ-5D Utility Score At Baseline, Progression-Free Survival, And Progression For Lenvatinib Versus Sorafenib

Hudgens, S ; Copher, R ; Meier, G

Value in health, 2018-05, Vol.21, p.S35-S35 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
PCN162 - Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib
PCN162 - Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib
Material Type:
Artigo 		Adicionar ao Meu Espaço

PCN162 - Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib

Hudgens, S ; Copher, R ; Meier, G

Value in health, 2018-05, Vol.21, p.S37-S37 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN
Material Type:
Artigo 		Adicionar ao Meu Espaço

PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN

Ikeda, S. ; Kudo, M. ; Izumi, N. ; Kaneko, S. ; Kobayashi, M. ; Azuma, M. ; Copher, R. ; Virabhak, S. ; Mitchell, D. ; Meier, G. ; Ishii, M.

Value in health, 2018-10, Vol.21, p.S46-S46 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology Group
EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

EPH80 Survival and Best Recorded Response (BRR) in Patients With Advanced Merkel Cell Carcinoma (MCC): Analysis of a Prospective German MCC Registry Study (MCC TRIM) of the German Dermatologic Cooperative Oncology Group

Mahmoudpour, S.H. ; Backer, J.C. ; Schadendorf, D. ; Leiter, U. ; Meier, F. ; Herbst, R. ; Grabbe, S. ; Mohr, P. ; Sachse, M.M. ; Pföhler, C. ; Gerbhardt, C. ; Ziller, F. ; Zimmer, L. ; Boutmy, E. ; Hoff, S. ; Verpillat, P. ; Milano, A.F. ; Shlaen, M. ; Fu, C. ; Ugurel, S.

Value in health, 2023-12, Vol.26 (12), p.S217 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2009  (1)
  2. 2009Até2010  (3)
  3. 2011Até2012  (3)
  4. 2013Até2014  (3)
  5. Após 2014  (12)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.